
Gleznor 30mg Tablet
Marketer
Costa Rich Pharmaceuticals
Salt Composition
Gliclazide (30mg)
Overview Gleznor 30mg Tablet
Diabetaid 30mg tablets are indicated for managing type 2 diabetes in adults. A sulfonylurea, Diabetaid helps regulate blood glucose, mitigating risks such as vision impairment and kidney complications. This medication may be used independently or in conjunction with other therapies and should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted. Continued use, even with controlled blood sugar, is crucial; premature discontinuation, without physician consultation, elevates the risk of complications including neuropathy, renal damage, and limb loss. This medication forms part of a comprehensive treatment plan encompassing dietary adjustments, regular physical activity, and weight management as advised by your doctor. Lifestyle factors significantly influence diabetes control. Common adverse effects include gastrointestinal discomfort and hypoglycemia (low blood sugar). Learn to recognize hypoglycemia symptoms (tremors, sweating, dizziness, headache) and appropriate management strategies; maintain regular meals and carry a readily available glucose source (e.g., juice, sweets). Alcohol consumption increases hypoglycemia risk and should be limited. Weight gain is a potential side effect. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of any prior history of heart, thyroid, or hormonal disorders before initiating treatment, as Diabetaid may be unsuitable. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are necessary.
Uses of Gleznor 30mg Tablet
Managing type 2 diabetes
Major Benefits of Gleznor 30mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the Gleznor 30mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Gleznor 30mg Tablet:
- Hypoglycemia (low blood glucose level)
- Weight gain
- Flatulence
- Diarrhea
- Headache
- Nausea
- Dizziness
How to use Gleznor 30mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gleznor 30mg Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
How Gleznor 30mg Tablet works:
This drug treats diabetes by stimulating pancreatic insulin secretion, thus reducing blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Gleznor 30mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Gleznor 30mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Gleznor 30mg Tablets. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneySAFE IF PRESCRIBED
Gleznor 30mg tablets are considered safe for individuals with kidney disease, and no dosage modification is advised. Nevertheless, its use is prohibited in patients exhibiting severe kidney impairment.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Gleznor 30mg tablets, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Gleznor 30mg Tablet :
Should you forget a Gleznor 30mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gleznor 30mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Improved sulfonylurea |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Actions | Sulfonylureas: Insulin Stimulators |
